CAMERON Associates
Home About Us Client News & Info Upcoming Client Events Contact Us Site Map
Select a Client

For more information please contact:
Kevin McGrath
212.245.4577
Kevin@cameronassoc.com

Misonix, Inc. (NASDAQ: MSON)
Misonix, Inc. (NASDAQ: MSON) designs, develops, manufactures, and markets, therapeutic ultrasonic medical devices, and laboratory equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually, Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.

November 13, 2008:
MISONIX REPORTS FIRST QUARTER FISCAL YEAR 2009 FINANCIAL RESULTS - download word.doc (40 Kb) »
November 5, 2008:
Misonix Announces new Distribution Agreement for The Netherlands
- download word.doc (40 Kb) »
November 4, 2008:
Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study
- download word.doc (40 Kb) »
November 3, 2008:
Misonix Announces Interim Distribution Agreement for Italy
- download word.doc (40 Kb) »
November 3, 2008:
Misonix Announces New Distribution Agreement for The United Kingdom and Ireland
- download word.doc (40 Kb) »
October 24, 2008:
Misonix Announces New Distribution Agreement for Greece
- download word.doc (40 Kb) »
October 29, 2008:
Misonix Announces new Distribution Agreement for Turkey
- download word.doc (40 Kb) »
October 27, 2008:
Misonix Expands Contract Sales Organization for Distribution of SonicOne™ Wound Management System in the United States
- download word.doc (40 Kb) »
September 24, 2008:
Misonic Reports Revenues for the Twelve Months Ended June 30, 2008 of $45.6 Million, Up 7.6% Compared to the Twelve Months Ended June 30, 2007
- download word.doc (40 Kb) »
August 25, 2008:
Misonix Announces New Distribution Agreement for the Czech Republic and the Slovak Republic
- download word.doc (40 Kb) »
August 11, 2008:
Misonix to Present at the Noble Financial Equity Conference
- download word.doc (40 Kb) »
July 17, 2008:
Misonix Recieves FDA Approval of Second Sonatherm® Soft Tissue Ablation System
- download word.doc (40 Kb) »
July 16, 2008:
Misonix Announces new Distribution Agreement for SONABLATE® in THE RUSSIAN FEDERATION
- download word.doc (40 Kb) »
July 7, 2008:
Misonix Appoints Neil Blewitt As Senior Managing Director of Labcaire
- download word.doc (40 Kb) »
July 2, 2008:
Misonix Announces the Closing of the USHIFU Agreement and the Receipt of $1.5 Million in Cash
- download word.doc (40 Kb) »
June 23, 2008:
Misonix Subsidiary Sonora Medical Announces Multiple Sales of its Advanced Acoustic Measurement System
- download word.doc (40 Kb) »
June 5, 2008:
Misonix Announces New Distribution Agreement for SonastarT BonescalpelT, and SonicOneT in italy
- download word.doc (40 Kb) »
May 20, 2008:
Misonix Announces Distribution Agreement for sonastarT and bonescalpelT
- download word.doc (40 Kb) »
May 8, 2008:
Misonix Reports an Increase in Revenues for the Three Months Ending March 31, 2008
- download word.doc (40 Kb) »
April 9, 2008:
MISONIX ANNOUNCES RETENTION OF CAMERON ASSOCIATES FOR INVESTOR RELATIONS SERVICES
- download word.doc (40 Kb) »
 

Quality Investor Relations Since 1976
© 2003 Cameron Associates. All rights reserved.